NFAT2 Regulates Anergy Induction in CLL through Lck

被引：0
|
作者：
Maerklin, Melanie [1 ]
Heitmann, Jonas S. [1 ]
Poljak, Alexandra [1 ]
Bugl, Stefanie [1 ]
Kopp, Hans-Georg [1 ]
Haap, Michael [1 ]
Kanz, Lothar [2 ]
Rao, Anjana [3 ]
Wirths, Stefan [1 ]
Mueller, Martin R. [1 ]
机构：
[1] Univ Tubingen, Tubingen, Germany
[2] Univ Tubingen Hosp, Tubingen, Germany
[3] La Jolla Inst Allergy & Immunol, La Jolla, CA USA
来源：
BLOOD | 2014年 / 124卷 / 21期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [1] NFAT2 regulates anergy induction in CLL through Lck
    Maerklin, M.
    Heitmann, J.
    Ganser, M.
    Bugl, S.
    Kopp, H. -G.
    Kanz, L.
    Rao, A.
    Wirths, S.
    Mueller, M. R.
    Oncology Research and Treatment, 2015, 38 : 200 - 200
  • [2] Nfat2 regulates anergy induction in CLL through Lck
    Maerklin, Melanie
    Heitmann, Jonas
    Ganser, Manuela
    Bugl, Stefanie
    Kopp, Hans-Georg
    Kanz, Lothar
    Rao, Anjana
    Wirths, Stefan
    Mueller, Martin R.
    LEUKEMIA & LYMPHOMA, 2015, 56 : 73 - 74
  • [3] NFAT2 to regulate anergy induction in CLL through Lck
    Maerklin, Melanie
    Heitmann, Jonas S.
    Truckenmueller, Felicia
    Ganser, Manuela
    Kopp, Hans-Georg
    Wirths, Stefan
    Kanz, Lothar
    Rao, Anjana
    Mueller, Martin Rudolf
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [4] NFAT2 is a critical regulator of anergy induction in CLL
    Maerklin, M.
    Heitmann, J. S.
    Poljak, A.
    Ganser, M.
    Evouna, C.
    Kopp, H. -G
    Kanz, L.
    Rao, A.
    Wirths, S.
    Mueller, M. R.
    ONCOLOGY RESEARCH AND TREATMENT, 2014, 37 : 236 - 236
  • [5] NFAT2 Is a Critical Regulator Of Anergy Induction In CLL
    Maerklin, Melanie
    Heitmann, Jonas S.
    Worbs, David
    Poljak, Alexandra
    Evouna, Claude
    Kopp, Hans-Georg
    Kanz, Lothar
    Rao, Anjana
    Wirths, Stefan
    Mueller, Martin R.
    BLOOD, 2013, 122 (21)
  • [6] Lck is a direct target gene of NFAT2 in CLL
    Fuchs, A. R.
    Maerklin, M.
    Heitmann, J. S.
    Truckenmueller, F. M.
    Saur, S. J.
    Ganser, M.
    Bugl, S.
    Kopp, H. -G.
    Kanz, L.
    Rao, A.
    Wirths, S.
    Mueller, M. R.
    ONCOLOGY RESEARCH AND TREATMENT, 2017, 40 : 26 - 26
  • [7] Transcriptional mistargeting of NFAT2 in CLL
    Maerklin, M.
    Heitmann, J. S.
    Poljak, A.
    Ganser, M.
    Evouna, C.
    Stickel, J.
    Kopp, H. -G
    Kanz, L.
    Rao, A.
    Wirths, S.
    Mueller, M. R.
    ONCOLOGY RESEARCH AND TREATMENT, 2014, 37 : 221 - 221
  • [8] Expression levels of NFAT2 and Lck show correlation with clinical outcome in CLL patients
    Heitmann, J. S.
    Fuchs, A. R.
    Mrklin, M.
    Kopp, H. -G.
    Quintanilla-Fend, L.
    Kanz, L.
    Rao, A.
    Wirths, S.
    Mueller, M. R.
    ONCOLOGY RESEARCH AND TREATMENT, 2017, 40 : 140 - +
  • [9] Overexpression and aberrant nuclear translocation of NFAT2 in CLL
    Heitmann, J. S.
    Maerkin, M.
    Worbs, D.
    Poljak, A.
    Stickel, J.
    Kanz, L.
    Wirths, S.
    Kopp, H-G
    Mueller, M. R.
    ONKOLOGIE, 2013, 36 : 222 - 222
  • [10] Genetic loss of NFAT2 leads to CLL transformation
    Fuchs, A. R.
    Maerklin, M.
    Heitmann, J. S.
    Truckenmueller, F. M.
    Sour, S. J.
    Ganser, M.
    Bugl, S.
    Kopp, H. -G
    Kanz, L.
    Rao, A.
    Wirths, S.
    Mueller, M. R.
    ONCOLOGY RESEARCH AND TREATMENT, 2016, 39 : 11 - 12
12345